Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
Clinical trial NCT01554852 · UNKNOWN
Trial details
- NCT number
- NCT01554852
- Sponsor
- University of Leeds
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2021-12-01
- Enrollment
- 4420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.